Surgical Guidance

Cairina Inc. provides technologies that non-invasively measure fluid flow in the body using MRI initially focusing on developing software that will predict where aggressive brain tumors are likely to progress and recur. We envision clinicians will use Cairina’s predictions to inform treatment for their patients, giving surgeons more precise regions to remove or administer higher doses of radiation. At Cairina’s core, our most important customer is the patient that will benefit through better, more individualized treatment planning, resulting in more time with loved ones.